
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















Histomorphological Effects of Vitamin E on Doxorubicin Induced- Skeletal Muscle Toxicity in a Male Wistar Rat Model
Author(s) | Ms. CHISEKWA CHIYANIKA, Careen Hankanga, Changula Katendi, Steward Mudenda, MbaweZulu, Mukape Mukape |
---|---|
Country | Zambia |
Abstract | Doxorubicin-induced skeletal muscle toxicity leads to muscle atrophy, inflammation,necrosis, and fibrosis, resulting in weakness, fatigue, and impaired quality of life in cancer patients.Vitamin E has antioxidant properties that may offer protective effects, but its role in mitigatingdoxorubicin-induced muscle toxicity remains unclear.Aim: This study evaluated the histomorphological protective effects of Vitamin E againstdoxorubicin-induced skeletal muscle toxicity in male Wistar rats, focusing on anatomical cross-sectional area (ACSA), inflammation, and muscle fascicle integrity.Methods: A randomized controlled trial was conducted using 42 male Wistar rats. The maintreatment group (n = 33) was divided into three subgroups: Negative Control, Doxorubicin-only,and Doxorubicin + Vitamin E. Vitamin E was administered orally from day 1, while doxorubicinwas introduced on day 28. ACSA was measured pre- and post-treatment using high-frequencyultrasound, and tibialis anterior muscle samples were analyzed histologically. Non-parametricstatistical tests were used, with significance set at p < 0.05.Results: Significant within-group ACSA differences were observed (p < 0.005), with highbetween-group significance (p < 0.001). Inflammation scores were significantly elevated in theDoxorubicin group (p = 0.035) but reduced in the Doxorubicin + Vitamin E group (p = 0.001).Muscle fascicle integrity remained unchanged.Conclusion: This study provides significant insights into the protective role of Vitamin E againsthistomorphological changes in skeletal muscle tissue induced by Doxorubicin. The findingssuggest that Vitamin E partially mitigates muscle atrophy by preserving the anatomical cross-sectional area of the tibialis anterior muscle. Additionally, it reduces the inflammatory response,thereby improving overall tissue integrity. However, its effect on muscle fascicle distortion remainsinconclusive, indicating the need for further investigation. These results highlight the potential ofVitamin E as a therapeutic adjunct in Doxorubicin-induced skeletal muscle toxicity, warrantingadditional research on its optimal dosage and efficacy in clinical settings. |
Keywords | Keywords: Skeletal Muscle Toxicity, Doxorubicin, Vitamin E, Inflammation, Histoprotective |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 4, July-August 2025 |
Published On | 2025-07-05 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.38964 |
Short DOI | https://doi.org/g9s895 |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
